Organized by Joshua T. Mendell of University of Texas Southwestern Medical Center, Phillip A. Sharp of Massachusetts Institute of Technology, Judy Lieberman of the Immune Disease Institute at Harvard University and Howard Y. Chang of Stanford University, the four-day conference will:
- Convene with keynote addresses by Jeannie T. Lee of Massachusetts General Hospital and V. Narry Kim of Seoul National University, followed by four days of informative plenary and poster sessions;
- Bring together a diverse, multidisciplinary group of scientists studying not only small noncoding RNAs but also longer ncRNAs that are increasingly shown to act as scaffolds or decoys to regulate critical cell fate decisions;
- Apply our understanding of noncoding RNA-regulated pathways to the development of novel therapeutic strategies for cancer and perhaps other diseases.